Yesterday, Boeing (BA) rose 0.8% (on a day the S&P 500 fell 0.1%) after reporting a big earnings beat. JPMorgan’s Seth Seifman and team explain why they’re staying on the sidelines:
BA outperformed by 100 bps yesterday after reporting a $2.05 guidance reduction that was below the $3.23 of charges announced last week. We assume there was some short covering here but on the fundamental side, we believe the strong BCA margin of 10.3% pleased investors, inspiring some confidence in management’s margin expansion plans. We are raising our BCA margin estimates, in part for a higher 787 booking rate and while this is only an accounting issue, it contributes to higher core EPS estimates. We are raising defense estimates too. We assume some more progress on BCA margins beyond 787 as well but plans for mid-teens here still strike us as quite ambitious. Management is very much focusing investor attention on its internal margin and cash generation efforts, which we view as a bid to reassure the market that the company can deliver cash flow and EPS growth in an order environment for commercial aircraft that is deteriorating, especially for wide bodies. In our view, investor concerns about demand remain a key issue for the stock and will continue to weigh on valuation. We reiterate our Neutral rating and our Dec 2016 price target is up $5 to $145.
Top 5 Dow Dividend Stocks To Watch Right Now: Barclays PLC(BCS)
Barclays PLC provides various financial products and services in Europe, the United States, Africa, and Asia. It offers retail and commercial banking, credit cards, investment banking, wealth management, and investment management services. The company?s products include current account and savings products, Woolwich branded mortgages, unsecured loans, protection products, general insurance, credit cards, Sharia-compliant products, installment finance and commercial property finance, commercial loans, and personal loans. It also offers money transmission, international and private banking, investment management, fiduciary, and brokerage services, as well as payment solutions and mobile banking services. In addition, the company provides fixed income, currency and commodities, foreign exchange, emerging markets, money markets, and credit services; equities, which include cash and equity derivatives and prime services; investment banking products and services that comprise fi nancial advisory, and equity and debt underwriting; and advisory services. It serves individual, commercial, corporate, institutional, retail, and mass affluent customers. The company was formerly known as Barclays Bank Limited and changed its name to Barclays PLC in January 1985. Barclays PLC was founded in 1896 and is headquartered in London, the United Kingdom.
- [By Wayne Duggan]
According to the 1/5 year CDS ratio, the banks that are most concerning to the market at the moment are Deutsche Bank AG (USA) (NYSE: DB), Credit Suisse Group AG (ADR) (NYSE: CS), Standard Chartered PLC (which trades on the LON exchange under the ticker “STAN”) and Barclays PLC (ADR) (NYSE: BCS).
Top 5 Dow Dividend Stocks To Watch Right Now: Exxon Mobil Corporation(XOM)
Exxon Mobil Corporation explores for and produces crude oil and natural gas in the United States, Canada/South America, Europe, Africa, Asia, and Australia/Oceania. It also manufactures and markets commodity petrochemicals, including olefins, aromatics, polyethylene and polypropylene plastics, and specialty products; and transports and sells crude oil, natural gas, and petroleum products. As of December 31, 2015, the company had approximately 35,909 gross and 30,114 net operated wells. Exxon Mobil Corporation was founded in 1870 and is headquartered in Irving, Texas.
- [By Philip Mause]
It is, of course, impossible to develop a universal corporate borrowing rate. I have conservatively used six per cent as a rate at which many of the large corporations can borrow money for 10 years. Readers should be aware that many, many large corporations can borrow at much, much lower rates. For example, Apple (AAPL) has 10 year bonds priced to yield 3.64%, Verizon (VZ) 3.55%, Bank of America (BAC) 4.06%, and AT&T (T) 4.15%. In this regard, the S&P 500 Index is weighted by market cap and so the impact of large companies with low borrowing costs – such as AAPL, Exxon (XOM), Microsoft (MSFT) and Verizon – is very large. Thus, the 6 per cent borrowing cost I am using for companies in the Index is very, very conservative. At any rate, I have assumed a 35% corporate tax rate and I have calculated the after tax borrowing cost, the PE, and the Index price which would correspond to various corporate interest rates using this Model.
- [By Ben Levisohn]
Should oil prices recover, we believe that deepwater drilling activity growth should lag growth in US shale activity, as project economics is generally better in US shales, and E&Ps involved in US shales are generally quicker to react. Deepwater activity is largely comprises a handful of companies (Petrobras (PBR), Statoil (STO), Total (TOT), Shell (RDS.A), BP (BP), ONGC, ExxonMobil (XOM) and Chevron (CVX)) and it is unlikely that these companies can meaningfully increase their rig demand in a short period of time to absorb the current oversupply. Thus, should oil prices rise in 2018, rig demand may increase, but likely not enough to tighten the market, given that supply equaling 43% of current working rig count is stacked and new supply equaling 25% of working rig count is under-construction and should be entering the market in the coming years. As a result, while we expect some improvement in rig utilization owing to rig retirements, it will unlikely be strong enough to meaningfully improve rates in 2018 above spot levels. Any demand increase in the interim could slow rig retirements materially, and be self-defeating. We thus are Sell rated on Transocean, Atwood and Noble.
- [By Javier Hasse]
Finally, some more popular stocks that saw net selling over July included Exxon Mobil Corporation (NYSE: XOM), Sprint Corp (NYSE: S) and LinkedIn Corp (NYSE: LNKD).
- [By Tyler Crowe]
Also, to comound these problems, there isn’t a clear leader of the project that can steer its investment deicisions. ExxonMobil (NYSE: XOM ) , Royal Dutch Shell (NYSE: RDS-A ) , Eni (NYSE: E ) , Total (NYSE: TOT ) , and Kazakh national oil company KazMunaiGas each have a16.81% working interest in the project. This has led to problems involving investment decisions and project mangement.BothExxonMobilandRoyal Dutch Shellhave been extremelydisappointedwith the results, to the point that they have threatened to pull out of the project altogether on a couple of occasions, andConocoPhillips (NYSE: COP ) did get out this year by selling its $5 billion stake in the project to China National Petroleum.
Top 10 Retail Stocks To Buy Right Now: Norwegian Cruise Line Holdings Ltd.(NCLH)
Norwegian Cruise Line Holdings Ltd. operates as a cruise line company that offers various itineraries. It offers cruises ranging from 1 day to 180 days itineraries to approximately 510 destinations worldwide. The company offers its products through independent travel agents, wholesalers, and tour operators. It operates 22 ships under the Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises brands with approximately 45,000 Berths. The company was founded in 1966 and is headquartered in Miami, Florida.
- [By Monica Gerson]
Norwegian Cruise Line Holdings Ltd (NASDAQ: NCLH) is expected to report its quarterly earnings at $0.37 per share on revenue of $1.10 billion.
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post its quarterly earnings at $2.31 per share on revenue of $338.86 million.
- [By Ben Levisohn]
Shares of Carnival have dropped 4.2% to $43.74 at 2:39 p.m. today, while Royal Caribbean Cruise (RCL) has tumbled 5.6% to $66.15, and Norwegian Cruise Line Holdings (NCLH) is off 4.3% at $38.63.
Top 5 Dow Dividend Stocks To Watch Right Now: Mead Johnson Nutrition Company(MJN)
Mead Johnson Nutrition Company (Mead Johnson), incorporated on December 17, 2008, is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company’s Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company markets its portfolio of approximately 70 products to mothers, healthcare professionals and retailers in over 50 countries in Asia, North America, Latin America and Europe.
The Company’s product portfolio, which addresses a range of pediatric nutritional needs, consists of two principal product categories: infant formula and children’s nutrition. The product categories are categorized into approximately five product types: routine infant, solutions, specialty, children’s nutrition and other. Its routine infant formula is intended for healthy consumers while its solutions and specialty products are offered for infants with special nutritional needs. The Company’s children’s’ nutrition products are designed to meet the nutritional needs of children at different stages of development. Its other products include vitamins and supplements.
Routine Infant Formula
The Company designs routine infant formula as a breast milk substitute for full-term infants without special nutritional needs both for the use as the infant’s source of nutrition and as a supplement to breastfeeding. Each product is referred to as a formula, as it is formulated for the specific nutritional needs of an i! nfant at a given age. Its routine infant formulas has over four components: protein from cow’s milk that is processed to have a profile similar to human milk; a blend of vegetable fats, including docosahexaenoic acid (DHA) and arachidonic acid (ARA), to replace bovine milk fat in order to resemble the composition of human milk; a carbohydrate, generally lactose from cow’s milk, and a vitamin and mineral micronutrient pre-mix that is blended into the product to meet the specific needs of the infant at a given age. The Company’s routine infant formula products include Enfamil Premium, Enfapro Premium, Enfamil A+ and Enfalac A+.
The Company designs several solutions formulas to address common feeding tolerance problems, including spit-up, fussiness, gas and lactose intolerance. Its solutions products include Enfamil Gentlease (for fussiness and gas), Enfamil A.R. (to reduce spit-up), Enfamil ProSobee (a soy-based formula) and Enfamil LactoFree (for lactose intolerance).
The Company designs specialty formulas to address certain conditions or special medical needs, including Nutramigen (for cow’s milk protein allergies) and Puramino (an amino acid formula for severe cow’s milk protein allergies or multiple other food allergies). The Company designs products, such as Enfamil Premature to meet the needs of premature and low birth weight infants under the supervision of a doctor, most often in the hospital, and EnfaCare, a hypercaloric formula for premature babies at home. It also produces medical foods, or foods for special medical purposes, for nutritional management of individuals with rare, inborn errors of metabolism, such as maple syrup urine disease (Mead Johnson BCAD) and phenylketonuria (Mead Johnson Phenyl-Free). Certain of these products are intended for infants and young children while others are suitable for children and adults.
Children’ s Nutrition Products
The Company designs its ch! ildren’s ! products to meet the nutritional needs of children at different stages of development (such as toddlers and older children). Its children’s nutrition products include Enfagrow, Sustagen and Lactum. These products are not breast milk substitutes and are not designed as a sole source of nutrition but instead are designed to be a part of a child’s diet. The Company also offers milk modifiers (ChocoMilk and Cal-C-Tose).
The Company also produces a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers, including Expecta and EnfaMama. Its pediatric vitamin products sold in a few geographies, such as Enfamil Poly-Vi-Sol, provide a range of benefits for infants, including multivitamins and iron supplements.
The Company competes with Abbott Laboratories, Danone and Nestle.
- [By Michael Flannelly]
On Tuesday, JP Morgan analysts upgraded children’s nutrition company Mead Johnson Nutrition (MJN), as they believe the company’s top line growth should be valued more highly than the possible cost headwinds and further Chinese regulations.
The analysts upgraded MJN from “Neutral” to “Overweight” and see shares reaching $88. This price target suggests a 16% upside to the stock’s Monday closing price of $76.11.
Mead Johnson Nutrition shares were up 85 cents, or 1.12%, during morning trading on Tuesday. The stock is up 16.71% year-to-date.
Top 5 Dow Dividend Stocks To Watch Right Now: Nomura Holdings Inc ADR(NMR)
Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and governmental agencies worldwide. It operates through three segments: Retail, Asset Management, and Wholesale. The Retail segment offers various financial products and investment services for individuals and corporations. As of March 31, 2015, this segment operated a network of 159 branches. The Asset Management segment is involved in the development and management of investment trusts, which offers low risk/low return products and high risk/high return products, as well as products for various investor needs; and provision of investment advisory services to public pension funds, private pension funds, governments and their agencies, central banks, and institutional investors. The Wholesale segment engages in the research, sale, trading, and market-making of fixed income and equity-related products. I t is also involved in underwriting various securities and other financial instruments, which include various stocks, convertible and exchangeable securities, investment grade debt, sovereign and emerging market debt, high yield debt, structured securities, and other securities; arranging private placements, as well as other capital raising activities; and the provision of financial advisory services on business transactions, including mergers and acquisitions, divestitures, spin-offs, capital structuring, corporate defense activities, leveraged buyouts, and risk solutions. In addition, this segment offers various financial instruments, such as equity securities, debt securities, investment trusts, and variable annuity insurance products for the short, medium, and long-term. The company was formerly known as The Nomura Securities Co., Ltd. and changed its name to Nomura Holdings, Inc. in October 2001. Nomura Holdings, Inc. was founded in 1925 and is headquartered in Tokyo, Ja pan.
- [By Maureen Farrell]
Shortly after Lehman declared bankruptcy, Barclays (BCS) paid $1.3 billion for most of the firm’s North American operations, its Times Square headquarters, and about 9,000 employees. Nomura Holdings (NMR) paid roughly $200 million for Lehman’s operations in Asia.